Miriam Kidron insider trades

Open-market stock purchases and sales by Miriam Kidron, Chief Scientific Officer at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Aug 14, 2007.

Recent trades

DateStockTradeValue
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$329K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$480K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$544K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$383K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$1M
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$1M
Mar 30, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$1.4M
Mar 25, 2026LFWD Lifeward LtdBought (not open market)—
Mar 17, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Jan 22, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Jan 14, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: 10 sales, last Sep 24, 2026
  • LFWD Lifeward Ltd: other filings, last Mar 25, 2026
  • ORMP.OB Oramed Pharmaceuticals Inc: other filings, last Aug 8, 2012

Get free alerts when Miriam Kidron files a new trade →